Anixa Biosciences, Inc.ANIXNASDAQ
Loading
Operating Income ContractionContracting
Percentile Rank40
Studio
Year-over-Year Change

Profit from core business operations before interest and taxes

Latest
$-11.03M
Near historical average
Percentile
P40
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-11.62M
Historical baseline
PeriodValueYoY Change
TTM$-11.03M+5.7%
2025$-11.70M+15.4%
2024$-13.83M-25.6%
2023$-11.01M+20.6%
2022$-13.88M-5.6%
2021$-13.14M-31.6%
2020$-9.98M+16.1%
2019$-11.89M+13.3%
2018$-13.71M-125.6%
2017$-6.08M-